Theravance Biopharma, Inc. (TBPH)

17.00 0.00 (0.00%) USD  |  NASDAQ  |  Aug 25, 10:10
More

Theravance Biopharma EPS Estimates for Next Quarter

EPS Estimates for Next Quarter Chart

View EPS Estimates for Next Quarter for TBPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for Next Quarter Chart
Start Trial

Historical EPS Estimates for Next Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 11, 2026 --
July 07, 2026 --
May 08, 2026 --
March 31, 2026 --
March 23, 2026 --
March 04, 2026 --
March 02, 2026 --
February 20, 2026 --
January 29, 2026 --
November 11, 2025 --
November 10, 2025 --
August 13, 2025 --
Date Value
May 09, 2025 --
April 08, 2025 --
February 27, 2025 --
February 25, 2025 --
February 21, 2025 --
November 13, 2024 --
August 06, 2024 --
May 23, 2024 --
May 14, 2024 --
March 05, 2024 --
February 27, 2024 --
February 23, 2024 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Next Quarter Range, Past 5 Years

View EPS Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Next Quarter Benchmarks

View EPS Estimates for Next Quarter Benchmarks
Start Trial
Zymeworks, Inc. Upgrade
Viatris, Inc. Upgrade
Ocular Therapeutix, Inc. Upgrade
ANI Pharmaceuticals, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade

EPS Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade